Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Quanterix Corp (QTRX) USD0.001

Sell:$27.75 Buy:$27.83 Change: $0.38 (1.35%)
Market closed |  Prices as at close on 18 February 2020 | Switch to live prices |
Sell:$27.75
Buy:$27.83
Change: $0.38 (1.35%)
Market closed |  Prices as at close on 18 February 2020 | Switch to live prices |
Sell:$27.75
Buy:$27.83
Change: $0.38 (1.35%)
Market closed |  Prices as at close on 18 February 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Quanterix Corporation develops ultra-sensitive digital immunoassay platform and tools for life science research and diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers. The Company is also focusing to enable and develop novel therapies and diagnostics to facilitate in healthcare for earlier detection, monitoring, prognosis and, ultimately, prevention of disease. Simoa focuses on research and clinical testing applications and significantly advances enzyme-linked immunosorbent assay (ELISA) technology which is capable of unprecedented protein detection sensitivity. It also focuses on research and diagnostics for brain injuries, heart disease, cancer and other infectious diseases with its technology. The Company offers Simoa HD-1 analyzer, which is an automated immunoassay platform with multiplexing and custom assay capability.

Contact details

Address:
900 Middlesex Tpke
BILLERICA
01821-3929
United States
Telephone:
+1 (617) 3019400
Website:
https://www.quanterix.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
QTRX
ISIN:
US74766Q1013
Market cap:
$790.30 million
Shares in issue:
28.01 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • E. Kevin Hrusovsky
    Chairman of the Board, President, Chief Executive Officer
  • Amol Chaubal
    Chief Financial Officer
  • David Duffy
    Senior Vice President, Research & Development and Chief Technology Officer
  • Dawn Mattoon
    Senior Vice President - Research Products
  • Mark Roskey
    Senior Vice President - Commercial and Accelerator

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.